(Q77425604)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Effects of a novel purine nucleoside phosphorylase inhibitor, BCX-34, on activation and proliferation of normal human lymphoid cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

R M Conry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Bantia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

H S Turner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

D L Barlow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

K O Allen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A F LoBuglio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J A Montgomery

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

G M Walsh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

1-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: the role of GTP and dGTP

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

Evidence for a pathway independent from 2'-deoxyguanosine and reversible by IL-2 by which purine nucleoside phosphorylase inhibitors block T-cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

Allosteric regulation of calf thymus ribonucleoside diphosphate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

Preliminary report on 8-amino-9-(2-thienylmethyl)guanine (PD 119,229), a novel and potent purine nucleoside phosphorylase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

Activities of two 9-deazaguanine analogue inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955, in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

T-lymphocyte-antigen interactions in transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

The T-cell receptor repertoire and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

A methodological study of E-rosette formation using AET-treated sheep red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(arylmethyl) derivatives of 9-deazaguanine

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

Different pathways for deoxyguanosine toxicity in T-lymphocytes of various developmental stages

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

1 reference

7 January 2021

Phytohemagglutinin binds to the 20-kDa molecule of the T3 complex

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. I. Suppression of the human mixed lymphocyte reaction (MLR).

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900012-5

7 January 2021

10.1016/S0162-3109(98)00012-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9776473%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference